Pay in 4 interest-free payments of $5.38 Learn more
Ships within 48 hours · Estimated delivery Aug 7 - Aug 12
When combined with baseline biomarker data (serum B12, methylmalonic acid, homocysteine) and a personalized provider conversation, genetic context can support more informed decision-making about whether MIC B12 fits your metabolic profile and goals
This comparative approach has provided valuable insights into the biology of the IGF axis and its implications for health and disease
The 8mg dose produced 21.1% average weight loss, which represents 88% of the maximum doses efficacy with meaningfully better tolerability
Clinical Outcomes: Parameter Baseline Current Weight 96 kg reduced to 81 kg HbA1c 9.8% to 5.8% RBS 380 to 140180 mg/dL LDL-C 188 to 120 mg/dL Triglycerides 396 to 166 mg/dL Liver Enzymes Elevated to Normalized Blood Pressure 130/85 to to100/70 mmHg Cardiometabolic Success at a Glance: ~15 kg weight reduction HbA1c improved from 9.8% to 5.8% Excellent glycemic control Significant improvement in LDL cholesterol Nearly 60% reduction in triglycerides Liver enzymes normalized Blood pressure optimized Marked overall improvement in cardiometabolic health Clinical Insights: This real-world case highlights the effectiveness of a comprehensive, patient-centered cardiometabolic approach, combining lifestyle modification with evidence-based pharmacotherapy
